Patrick J. Flynn - Nov 28, 2022 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
Director
Signature
/s/ Patrick J Flynn
Stock symbol
NRXP
Transactions as of
Nov 28, 2022
Transactions value $
$14,663
Form type
4
Date filed
11/29/2022, 06:00 AM
Previous filing
Nov 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRXP Common Stock, par value $0.001 per share Purchase $3.13K +2.5K +7.1% $1.25 37.7K Nov 28, 2022 By Trust F1
transaction NRXP Common Stock, par value $0.001 per share Purchase $3.13K +2.5K +6.63% $1.25 40.2K Nov 28, 2022 By Trust F2
transaction NRXP Common Stock, par value $0.001 per share Purchase $3.13K +2.5K +7.1% $1.25 37.7K Nov 28, 2022 By Trust F3
transaction NRXP Common Stock, par value $0.001 per share Purchase $3.1K +2.5K +6.63% $1.24 40.2K Nov 28, 2022 By Trust F4
transaction NRXP Common Stock, par value $0.001 per share Purchase $2.19K +1.75K $1.25 1.75K Nov 28, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by the Whitney Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.
F2 Held by the Whitney Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.
F3 Held by the Lindsay Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.
F4 Held by the Lindsay Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.